These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 2392948

  • 1. Model investigation of the mechanisms of conductance along excitable fibres in the recovery cycle.
    Stephanova D.
    Acta Physiol Pharmacol Bulg; 1990; 16(1):14-7. PubMed ID: 2392948
    [Abstract] [Full Text] [Related]

  • 2. Mathematical analysis of the changes in the parameters of the action potentials, membrane and ionic currents of frog muscle fibre during the recovery cycle.
    Stephanova DI.
    Biol Cybern; 1987; 57(3):207-11. PubMed ID: 3676358
    [Abstract] [Full Text] [Related]

  • 3. Velocity recovery cycles of human muscle action potentials and their sensitivity to ischemia.
    Z'graggen WJ, Bostock H.
    Muscle Nerve; 2009 May; 39(5):616-26. PubMed ID: 19229874
    [Abstract] [Full Text] [Related]

  • 4. Conduction along myelinated and demyelinated nerve fibres during the recovery cycle: model investigations.
    Stephanova DI.
    Biol Cybern; 1989 May; 62(1):83-7. PubMed ID: 2590680
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differences in potentials and excitability properties in simulated cases of demyelinating neuropathies. Part I.
    Stephanova DI, Daskalova M, Alexandrov AS.
    Clin Neurophysiol; 2005 May; 116(5):1153-8. PubMed ID: 15826856
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differences in potentials and excitability properties in simulated cases of demyelinating neuropathies. Part II. Paranodal demyelination.
    Stephanova DI, Daskalova M.
    Clin Neurophysiol; 2005 May; 116(5):1159-66. PubMed ID: 15826857
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A rat in vitro model for the measurement of multiple excitability properties of cutaneous axons.
    Maurer K, Bostock H, Koltzenburg M.
    Clin Neurophysiol; 2007 Nov; 118(11):2404-12. PubMed ID: 17897875
    [Abstract] [Full Text] [Related]

  • 12. Muscle fiber recovery functions studied with double pulse stimulation.
    Mihelin M, Trontelj JV, Stålberg E.
    Muscle Nerve; 1991 Aug; 14(8):739-47. PubMed ID: 1890998
    [Abstract] [Full Text] [Related]

  • 13. Differences in potentials and excitability properties in simulated cases of demyelinating neuropathies. Part III. Paranodal internodal demyelination.
    Stephanova DI, Daskalova M.
    Clin Neurophysiol; 2005 Oct; 116(10):2334-41. PubMed ID: 16122981
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Simulation of the interaction between muscle fiber conduction velocity and instantaneous firing rate.
    Fortune E, Lowery MM.
    Ann Biomed Eng; 2011 Jan; 39(1):96-109. PubMed ID: 20848314
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neuromuscular excitability properties in myotonic dystrophy type 1.
    Boërio D, Hogrel JY, Bassez G, Lefaucheur JP.
    Clin Neurophysiol; 2007 Nov; 118(11):2375-82. PubMed ID: 17890147
    [Abstract] [Full Text] [Related]

  • 20. Nerve excitability--toward an integrating concept.
    Neumann E, Nachmansohn D.
    Biomembranes; 1975 Nov; 7():99-166. PubMed ID: 1092381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.